KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Exchange Rate Effect (2016 - 2025)

Opko Health's Exchange Rate Effect history spans 16 years, with the latest figure at $174000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect changed N/A year-over-year to $174000.0; the TTM value through Dec 2025 reached $3.4 million, changed N/A, while the annual FY2025 figure was $3.4 million, 208.62% up from the prior year.
  • Exchange Rate Effect reached $174000.0 in Q4 2025 per OPK's latest filing, up from -$316000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $2.4 million in Q3 2024 to a low of -$1.3 million in Q4 2021.
  • Average Exchange Rate Effect over 5 years is $183388.9, with a median of -$35500.0 recorded in 2024.
  • Peak YoY movement for Exchange Rate Effect: crashed 531.86% in 2021, then surged 696.33% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$1.3 million in 2021, then soared by 233.52% to $1.7 million in 2022, then tumbled by 57.5% to $723000.0 in 2023, then skyrocketed by 231.81% to $2.4 million in 2024, then tumbled by 92.75% to $174000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPK's Exchange Rate Effect are $174000.0 (Q4 2025), -$316000.0 (Q3 2025), and $1.5 million (Q2 2025).